女性の健康:医療機器パイプライン分析

◆英語タイトル:Women's Health - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0161
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:603
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Women’s Health – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Women’s Health – Medical Devices Pipeline Assessment, 2019″ provides an overview of Women’s Health currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Women’s Health pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Women’s Health under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Women’s Health and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Women’s Health under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 17
1.2 List of Figures 28
2 Introduction 29
2.1 Women’s Health Overview 29
3 Products under Development 30
3.1 Women’s Health – Pipeline Products by Stage of Development 30
3.2 Women’s Health – Pipeline Products by Territory 31
3.3 Women’s Health – Pipeline Products by Regulatory Path 33
3.4 Women’s Health – Pipeline Products by Estimated Approval Date 34
3.5 Women’s Health – Ongoing Clinical Trials 35
4 Women’s Health – Pipeline Products under Development by Companies 36
4.1 Women’s Health Companies – Pipeline Products by Stage of Development 36
4.2 Women’s Health – Pipeline Products by Stage of Development 41
5 Women’s Health Companies and Product Overview 47
5.1 AblaCare Company Overview 47
5.1.1 AblaCare Pipeline Products & Ongoing Clinical Trials Overview 47
5.2 AdneXXA LLC Company Overview 50
5.2.1 AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview 50
5.3 Advanced Prenatal Therapeutics, Inc. Company Overview 51
5.3.1 Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.4 Advanced Tactile Imaging Inc Company Overview 52
5.4.1 Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.5 AEGEA Medical Inc Company Overview 55
5.5.1 AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.6 Aethlon Medical Inc Company Overview 56
5.6.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.7 Agile Therapeutics Inc Company Overview 57
5.7.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.8 Allergan Plc Company Overview 60
5.8.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 60
5.9 AltaScience Limited Company Overview 62
5.9.1 AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview 62
5.10 Alydia Health Inc Company Overview 63
5.10.1 Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.11 Amniotix Technologies Ltd Company Overview 66
5.11.1 Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
5.12 ANALYTICA PTY LTD Company Overview 67
5.12.1 ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview 67
5.13 Aneeve Nanotechnologies LLC Company Overview 68
5.13.1 Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 Aspivix SA Company Overview 69
5.14.1 Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview 69
5.15 Bayer AG Company Overview 70
5.15.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 70
5.16 Baystate Medical Center Company Overview 72
5.16.1 Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 72
5.17 Becton Dickinson and Co Company Overview 73
5.17.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 73
5.18 BeFree! Company Overview 76
5.18.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview 76
5.19 BellaSeno GmbH Company Overview 77
5.19.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 77
5.20 Bewell Connect Corp Company Overview 78
5.20.1 Bewell Connect Corp Pipeline Products & Ongoing Clinical Trials Overview 78
6 Women’s Health- Recent Developments 289
6.1 Nov 19, 2019: Edan to highlight its new developments at MEDICA 2019 289
6.2 Nov 19, 2019: Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China 289
6.3 Nov 18, 2019: A new self-use innovative treatment for pelvic organ prolapse in women (POP) designed by ConTIPI Medical 290
6.4 Nov 18, 2019: Barbro Friden steps down as a member of the board of Vitrolife 291
6.5 Nov 14, 2019: Merck acquires Calporta Therapeutics for $576m 291
6.6 Nov 14, 2019: INVO Bioscience reports third quarter 2019 financial results 291
6.7 Nov 13, 2019: BellaSeno and Evonik to launch 3D-printed absorbable breast scaffold 293
6.8 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 294
6.9 Nov 13, 2019: Atossa Genetics announces third quarter 2019 financial results and provides company update 294
6.10 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 296
7 Appendix 600
7.1 Methodology 600
7.2 About GlobalData 603
7.3 Contact Us 603
7.4 Disclaimer 603

List of Tables
Table 1: Women's Health - Pipeline Products by Stage of Development
Table 2: Women's Health - Pipeline Products by Territory
Table 3: Women's Health - Pipeline Products by Regulatory Path
Table 4: Women's Health - Pipeline Products by Estimated Approval Date
Table 5: Women's Health - Ongoing Clinical Trials
Table 6: Women's Health Companies - Pipeline Products by Stage of Development
Table 7: Women's Health - Pipeline Products by Stage of Development
Table 8: AblaCare Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AblaCare Kit - Product Status
Table 10: AblaCare Kit - Product Description
Table 11: AblaCare - Ongoing Clinical Trials Overview
Table 12: AblaCare Kit - ULTRA Study: A Feasibility, Prospective, Multicenter, Single-arm Trial of the AblaCare Device in Transvaginal Ablation of Ovarian Tissue Under Ultrasound Visualisation in Women with Polycystic Ovary Syndrome (PCOS)
Table 13: AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Reusable Contraception Device - Product Status
Table 15: Reusable Contraception Device - Product Description
Table 16: Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Targeted Apheresis Column for Preeclampsia (TAC-PE) - Product Status
Table 18: Targeted Apheresis Column for Preeclampsia (TAC-PE) - Product Description
Table 19: Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Antepartum Tactile Imager - Product Status
Table 21: Antepartum Tactile Imager - Product Description
Table 22: Cervix Monitor - Product Status
Table 23: Cervix Monitor - Product Description
Table 24: Restore-IT - Product Status
Table 25: Restore-IT - Product Description
Table 26: AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Next-Generation Adaptive Vapor Ablation System - Product Status
Table 28: Next-Generation Adaptive Vapor Ablation System - Product Description
Table 29: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: HER2osome - Product Status
Table 31: HER2osome - Product Description
Table 32: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: AG200-ER Patch - Product Status
Table 34: AG200-ER Patch - Product Description
Table 35: AG200-SP Patch - Product Status
Table 36: AG200-SP Patch - Product Description
Table 37: AG890 Patch - Product Status
Table 38: AG890 Patch - Product Description
Table 39: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Norethindrone Transdermal Delivery System - Product Status
Table 41: Norethindrone Transdermal Delivery System - Product Description
Table 42: Smooth 133 Plus TE - Product Status
Table 43: Smooth 133 Plus TE - Product Description
Table 44: AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 45: AltaSeal - Product Status
Table 46: AltaSeal - Product Description
Table 47: Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: InPress Postpartum Hemorrhage Intrauterine Device - Product Status
Table 49: InPress Postpartum Hemorrhage Intrauterine Device - Product Description
Table 50: Alydia Health Inc - Ongoing Clinical Trials Overview
Table 51: InPress Postpartum Hemorrhage Intrauterine Device - Potential Approach to Treat Postpartum Hemorrhage Using InPress Postpartum Hemorrhage Intrauterine Device
Table 52: InPress Postpartum Hemorrhage Intrauterine Device - Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
Table 53: Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Amniotic Fluid Spectral Monitoring Device - Product Status
Table 55: Amniotic Fluid Spectral Monitoring Device - Product Description
Table 56: ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 57: PeriCoach System - Pelvic Organ Prolapse - Product Status
Table 58: PeriCoach System - Pelvic Organ Prolapse - Product Description
Table 59: Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Hormone Level Monitor - Product Status
Table 61: Hormone Level Monitor - Product Description
Table 62: Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Aspivix Device - Product Status
Table 64: Aspivix Device - Product Description
Table 65: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 66: LNG-IUS16 - Product Status

List of Figures
Figure 1: Women's Health - Pipeline Products by Stage of Development
Figure 2: Women's Health - Pipeline Products by Territory
Figure 3: Women's Health - Pipeline Products by Regulatory Path
Figure 4: Women's Health - Pipeline Products by Estimated Approval Date
Figure 5: Women's Health - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[女性の健康:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆